BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

• Main Authors: A. Barnadas (Author), M. Muñoz (Author), M. Margelí (Author), J. I. Chacón (Author), J. Cassinello (Author), S. Antolin (Author), E. Adrover (Author), M. Ramos (Author), E. Carrasco (Author), M. A. Jimeno (Author), B. Ojeda (Author), X. González (Author), S. González (Author), M. Constenla (Author), J. Florián (Author), A. Miguel (Author), A. Llombart (Author), A. Lluch (Author), M. Ruiz-Borrego (Author), R. Colomer (Author), S. Del Barco (Author), On behalf of GEICAM, Spanish Breast Cancer Group (Author)
• Format: Book
• Published: SpringerOpen, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties of the Bone Metastasis Quality of Life (BOMET-QoL-10) measure on MBC patients...